View Original Post on HME News
ESPOO, Finland – Finnish health tech company Medixine has strengthened its presence in the U.S. market with “a deepened technological partnership” with Nonin Medical, a manufacturer of wearable and noninvasive medical monitoring devices. The new partnership will combine Medixine’s digital remote patient monitoring software platform with Nonin’s pulse oximetry devices. “In deepening our partnership with Nonin Medical, we’re setting ambitious goals together to bring remote digital care’s substantial benefits to both patients and clinicians across the United States,” said Lasse Rousi, CEO at Medixine. “The U.S. is an important market for Medixine; demand for remote patient care is high, as there are often vast distances between patients and health care providers. Furthermore, it’s especially significant for us that a renowned market leader like Nonin Medical has chosen our remote patient monitoring platform for its first transition from devices into digital services.” Medixine, which is currently active in eight countries (Finland, U.S., U.K., Sweden, Norway, Denmark, Spain and Portugal), covers a patient population of 2.5 million. The companies expect the partnership to, among other things, advance efforts to use overnight oximetry during sleep as a pre-screening tool to determine if patients need and qualify for supplemental oxygen or need to be tested further for sleep disorders. “Combining physical monitoring devices with Medixine’s digital platform offers huge potential benefits in understanding the need for overnight oxygen,” said Aaron Lobbestael, senior director of advanced technology at Nonin Medical. “At present, it may take months to acquire an accurate reading using overnight devices that patients need to take to and from the health care provider multiple times. Our digital solution would require just one night of measurement, which would be downloaded automatically to the patient’s records. By digitizing our healthcare services, patients can access all the same services they have received previously, but much more easily, while clinicians’ workflows are made significantly more efficient.”